Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Our AI ranks Cannabis Bioscience International Holdings, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given. Its Current Ratio of 0.00x is the lowest of the 16 peers that report one.
For CBIH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 9.0%, measured on 302 forecast dates between 2023-08-18 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -12.0%, measured on 345 forecast dates between 2023-08-18 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CBIH included.
Follow CBIH free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Commercial Physical & Biological Research peers listed below that report each metric.
| Metric | CBIH | Rank |
|---|---|---|
| EPS | $0.00 | – |
| Metric | CBIH | Rank |
|---|---|---|
| ROA | -31398.1% | 11/11 |
| ROIC | 32.3% | 3/11 |
| Gross Margin | 60.3% | 3/7 |
| Operating Margin | -379.5% | 10/13 |
| Net Margin | -467.9% | 9/10 |
| EBT Margin | -379.5% | 10/13 |
| Tax Rate | 0.0% | – |
| Metric | CBIH | Rank |
|---|---|---|
| Current Ratio | 0.00x | 16/16 |
| Interest Coverage | -2.7x | 7/13 |
| Working Capital | -$1M | 8/15 |
| Metric | CBIH | Rank |
|---|---|---|
| Operating Cash Flow | -$280K | 8/15 |
| Metric | CBIH | Rank |
|---|---|---|
| Operating Income | -$390K | 8/15 |
| Net Income | -$480K | 7/12 |
| Cost of Goods Sold | $40K | 8/8 |
| Total Current Assets | $0.00M | |
| Cash & Short-term Investments | $0.00M | |
| Accounts Receivable | $0.00M | |
| Total Liabilities | $1M |
Companies classified under the same SEC industry code as Cannabis Bioscience International Holdings, Inc. (Services-Commercial Physical & Biological Research): 16 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CBIH Cannabis Bioscience International Holdings, Inc. | ▼ | N/A |
| IQV Iqvia Holdings Inc. | ▼ | $45.37B |
| INCY Incyte Corp | ▶ | $22.20B |
| MEDP Medpace Holdings, Inc. | ▼ | $17.26B |
| CRL Charles River Laboratories International, Inc. | ▶ | $14.33B |
| ICLR Icon Plc | ▶ | $13.13B |
| ABSI Absci Corp | ▲ | $1.42B |
| OABI Omniab, Inc. | ▲ | $667M |
| NRC Nrc Health | ▲ | $446M |
| MXCT Maxcyte, Inc. | ▲ | $134M |
| ONMD Onemednet Corp | ▲ | $28M |
| VSBC Vitaspring Biomedical Co. Ltd. | ▼ | $7M |
| BIAF Bioaffinity Technologies, Inc. | ▼ | $5M |
| BUDZ Weed, Inc. | ▲ | $3M |
| ISPC Ispecimen Inc. | ▼ | $3M |
| FOXO Foxo Technologies Inc. | ▼ | $180K |
Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for CANNABIS BIOSCI INTL HLDG by CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.. Use the full ...
A high-level overview of Cannabis Bioscience International Holdings, Inc. (CBIH) stock. View (CBIH) real-time stock price, chart, news, analysis, analyst reviews and more.
Houston, Texas--(Newsfile Corp. - June 22, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today ...
Our AI ranks Cannabis Bioscience International Holdings, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For CBIH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 9.0%, measured on 302 forecast dates between 2023-08-18 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -12.0%, measured on 345 forecast dates between 2023-08-18 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Cannabis Bioscience International Holdings, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
16 issuers in our coverage, CBIH included, share the SEC industry code Services-Commercial Physical & Biological Research. The largest are: Iqvia Holdings Inc. (IQV), Incyte Corp (INCY), Medpace Holdings, Inc. (MEDP), Charles River Laboratories International, Inc. (CRL), Icon Plc (ICLR), Absci Corp (ABSI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.